-
1
-
-
0026072812
-
Bone protein and peptide assays in the diagnosis and management of skeletal disease
-
Dcftos LI: Bone protein and peptide assays in the diagnosis and management of skeletal disease. Clin Chem 1991:37:1143-1148.
-
(1991)
Clin Chem
, vol.37
, pp. 1143-1148
-
-
Dcftos, L.I.1
-
2
-
-
0024095166
-
Biology of Disease Morphology and biochemistry of bone remodeling: Possible control by vitamin D, parathyroid hormone, and other substances
-
Huffer WE: Biology of Disease Morphology and biochemistry of bone remodeling: Possible control by vitamin D, parathyroid hormone, and other substances. Lab Invest 1988:59:418-442.
-
(1988)
Lab Invest
, vol.59
, pp. 418-442
-
-
Huffer, W.E.1
-
3
-
-
0022590234
-
Kinetic and cytochemical identification of osteoclast precursors and their differentiation into multinucleated osteoclasts
-
Baron R, Neff L, Tran Van P, Nefuss R, Vignercy A: Kinetic and cytochemical identification of osteoclast precursors and their differentiation into multinucleated osteoclasts. Am J Pathol 1986:122:363-378.
-
(1986)
Am J Pathol
, vol.122
, pp. 363-378
-
-
Baron, R.1
Neff, L.2
Tran Van, P.3
Nefuss, R.4
Vignercy, A.5
-
4
-
-
0026687385
-
Biochemistry of articular cartilage in health and disease
-
Kuettner KE: Biochemistry of articular cartilage in health and disease. Clin Biochem 1992:25:155-163.
-
(1992)
Clin Biochem
, vol.25
, pp. 155-163
-
-
Kuettner, K.E.1
-
5
-
-
0020517288
-
Crosslinking of collagen: Isolation, structural characterization and glycosylation of pyridino-line
-
Robins SP: Crosslinking of collagen: Isolation, structural characterization and glycosylation of pyridino-line. Biochem J 1983:215:167-173.
-
(1983)
Biochem J
, vol.215
, pp. 167-173
-
-
Robins, S.P.1
-
6
-
-
0020561714
-
Cross-linking of collagen. Location of pvridinolinc in bovine articular cartilage at two sites of the molecule
-
Robins SP, Duncan A: Cross-linking of collagen. Location of pvridinolinc in bovine articular cartilage at two sites of the molecule. Biochem J 1983:2115: 175-182.
-
(1983)
Biochem J
, vol.2115
, pp. 175-182
-
-
Robins, S.P.1
Duncan, A.2
-
7
-
-
0020065112
-
Enzyme immunoassay for tartrate-resistant acid phosphatase
-
Lam K-W, Siemens M, Sun T, Li C-Y, Yam LT: Enzyme immunoassay for tartrate-resistant acid phosphatase. Clin Chem 1982:28:467-470.
-
(1982)
Clin Chem
, vol.28
, pp. 467-470
-
-
Lam, K.-W.1
Siemens, M.2
Sun, T.3
Li, C.-Y.4
Yam, L.T.5
-
8
-
-
0026341027
-
Biochemical markers of bone turnover: Methodology and clinical use in osteoporosis
-
Delmas PD: Biochemical markers of bone turnover: Methodology and clinical use in osteoporosis. Am J Med 1991:91:5B-59S -5B-63S.
-
(1991)
Am J Med
, vol.91
, pp. 5B-59S-5B-63S
-
-
Delmas, P.D.1
-
9
-
-
0028911079
-
Immunoassay of a tartrate-resistant acid phosphatase in serum
-
Cheung CK, Panesar NS, Haines C, Masarci J, Swaminathan R: Immunoassay of a tartrate-resistant acid phosphatase in serum. Clin Chem 1995: 41:679-686.
-
(1995)
Clin Chem
, vol.41
, pp. 679-686
-
-
Cheung, C.K.1
Panesar, N.S.2
Haines, C.3
Masarci, J.4
Swaminathan, R.5
-
10
-
-
0020622337
-
Proteins involved in the activation and control of the two pathways of human complement
-
Reid KBM: Proteins involved in the activation and control of the two pathways of human complement. Biochem SocTrans 1982:11:1-11.
-
(1982)
Biochem Soctrans
, vol.11
, pp. 1-11
-
-
Reid, K.1
-
11
-
-
0026491014
-
Bone-resorption markers galactosyl hvdroxylysine. Pyridinium crosslinks, and hydroxyproline compared
-
Bettica P, Moro L, Robins SP, Taylor AK. Talbot J, Singer FR, Baylink DJ: Bone-resorption markers galactosyl hvdroxylysine. pyridinium crosslinks, and hydroxyproline compared. Clin Chem 1992:38: 2313-2318.
-
(1992)
Clin Chem
, vol.38
, pp. 2313-2318
-
-
Bettica, P.1
Moro, L.2
Robins, S.P.3
Taylor, A.K.4
Talbot, J.5
Singer, F.R.6
Baylink, D.J.7
-
12
-
-
0026486733
-
New biochemical marker for bone disease: Is it a breakthrough?
-
Demers LM: New biochemical marker for bone disease: Is it a breakthrough? Clin Chem 1992:38: 2169-2170.
-
(1992)
Clin Chem
, vol.38
, pp. 2169-2170
-
-
Demers, L.M.1
-
13
-
-
0028535231
-
Recent advances in biochemical markers of bone turnover
-
Demers LM: Recent advances in biochemical markers of bone turnover. Clin Chem 1994:40: 1994-1995.
-
(1994)
Clin Chem
, vol.40
, pp. 1994-1995
-
-
Demers, L.M.1
-
14
-
-
8944232467
-
Bestimmung der Hydroxypyridinium-Crosslinks als Knochenabbau-Parameter mittels HPLC und Immunoassay
-
Engler H, Lenz A, Riesen WF: Bestimmung der Hydroxypyridinium-Crosslinks als Knochenabbau-Parameter mittels HPLC und Immunoassay. Lab Med 1995:17:256-259.
-
(1995)
Lab Med
, vol.17
, pp. 256-259
-
-
Engler, H.1
Lenz, A.2
Riesen, W.F.3
-
15
-
-
0028111819
-
Urinary hydroxypyridinium crosslinks of collagen in population-based screening for overt vertebral osteoporosis: Results of a pilot study
-
Scibcl MJ, Woitge H, Scheidt-Nave C, Leidig-Bruckner G, Duncan A, Nicol P, Ziegler R, Robins SP: Urinary hydroxypyridinium crosslinks of collagen in population-based screening for overt vertebral osteoporosis: Results of a pilot study. J Bone Miner Res 1994:9:1433-1440.
-
(1994)
J Bone Miner Res
, vol.9
, pp. 1433-1440
-
-
Scibcl, M.J.1
Woitge, H.2
Scheidt-Nave, C.3
Leidig-Bruckner, G.4
Duncan, A.5
Nicol, P.6
Ziegler, R.7
Robins, S.P.8
-
16
-
-
0028815664
-
Pyridinium-Crosslinks: Sind die Resultate der freien PYD-. DPD-Bestimmung als Knochen-Resorptionsmarker vergleichbar zu denjenigen der Gesamt PYD-. DPD-Konzcntra-tion?
-
Engler H, Riesen W: Pyridinium-Crosslinks: Sind die Resultate der freien PYD-. DPD-Bestimmung als Knochen-Resorptionsmarker vergleichbar zu denjenigen der Gesamt PYD-. DPD-Konzcntra-tion? Clin Lab 1995:41:893-896.
-
(1995)
Clin Lab
, vol.41
, pp. 893-896
-
-
Engler, H.1
Riesen, W.2
-
17
-
-
0027992985
-
Nocturnal rise in markers of bone resorption is not abolished by bedtime calcium or calcitonin
-
Sairanen S, Tähtelä R, Laitinen K, Karonen SL, Välimäki MJ: Nocturnal rise in markers of bone resorption is not abolished by bedtime calcium or calcitonin. Calcif Tissue Ini 1994:55:349-352.
-
(1994)
Calcif Tissue Ini
, vol.55
, pp. 349-352
-
-
Sairanen, S.1
Tähtelä, R.2
Laitinen, K.3
Karonen, S.L.4
Välimäki, M.J.5
-
18
-
-
0027417926
-
Radioimmunoassay for the pvridinolinc cross-linked carboxy-terminal telopeptide of type I collagen: A new serum marker of bone collagen degradation
-
Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L: Radioimmunoassay for the pvridinolinc cross-linked carboxy-terminal telopeptide of type I collagen: A new serum marker of bone collagen degradation. Clin Chem 1993:39:635-640.
-
(1993)
Clin Chem
, vol.39
, pp. 635-640
-
-
Risteli, J.1
Elomaa, I.2
Niemi, S.3
Novamo, A.4
Risteli, L.5
-
19
-
-
0028923618
-
Application of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): Follow-up on hormone replacement therapy and osteoporosis risk assessment
-
Bonde M, Ovist P, Fledelius C, Riis BJ, Christiansen C: Application of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): Follow-up on hormone replacement therapy and osteoporosis risk assessment. J Clin Endocrinol Metab 1995:80:864-868.
-
(1995)
J Clin Endocrinol Metab
, vol.80
, pp. 864-868
-
-
Bonde, M.1
Ovist, P.2
Fledelius, C.3
Riis, B.J.4
Christiansen, C.5
-
20
-
-
0026508311
-
Preliminary results of the use of urinary excretion of pyridinium crosslinks for monitoring metastatic bone disease
-
Coleman RE, Houston S, James I, Rodger A, Rubens RD, Leonard RCF, Ford J: Preliminary results of the use of urinary excretion of pyridinium crosslinks for monitoring metastatic bone disease. Br J Cancer 1992:65:766-768.
-
(1992)
Br J Cancer
, vol.65
, pp. 766-768
-
-
Coleman, R.E.1
Houston, S.2
James, I.3
Rodger, A.4
Rubens, R.D.5
Leonard, R.6
Ford, J.7
-
21
-
-
0028941663
-
Double-blind, placebo-controlled, dose-rcsponsc trial of oral elodronate in patients with bone metastases
-
O'Rourke N, McCloskey E, Houghton F, Huss H, Kanis JA: Double-blind, placebo-controlled, dose-rcsponsc trial of oral elodronate in patients with bone metastases. J Clin Oncol 1995:13:929-934.
-
(1995)
J Clin Oncol
, vol.13
, pp. 929-934
-
-
O'rourke, N.1
McCloskey, E.2
Houghton, F.3
Huss, H.4
Kanis, J.A.5
-
22
-
-
0027050850
-
Newly identified actions of the vitamin D endocrine system
-
Walters MR: Newly identified actions of the vitamin D endocrine system. F.ndocr Rev 1992:13:719-764.
-
(1992)
F.Ndocr Rev
, vol.13
, pp. 719-764
-
-
Walters, M.R.1
-
23
-
-
0028821040
-
The diagnostic value of urinary pyridium cross-links of collagen, serum total alkaline phosphatase, and urinary calcium excretion in neoplastic hone disease
-
Pecherstorfer M, Zimmer-Roth I, Schilling T, et al: The diagnostic value of urinary pyridium cross-links of collagen, serum total alkaline phosphatase, and urinary calcium excretion in neoplastic hone disease. J Clin Endocrinol Metab 1995:80: 97-103.
-
(1995)
J Clin Endocrinol Metab
, vol.80
, pp. 97-103
-
-
Pecherstorfer, M.1
Zimmer-Roth, I.2
Schilling, T.3
-
24
-
-
0025335416
-
Age and sex distribution of alkaline phosphatase isoenzymes by agarose electrophoresis
-
Van Hoof VO, Hoylaerts MF, Geryl H, Vim Mullem M, Lepoutre LG, De Broe M: Age and sex distribution of alkaline phosphatase isoenzymes by agarose electrophoresis. Clin Chcm 1990:36:875-878.
-
(1990)
Clin Chcm
, vol.36
, pp. 875-878
-
-
Van Hoof, V.O.1
Hoylaerts, M.F.2
Geryl, H.3
Vim Mullem, M.4
Lepoutre, L.G.5
De Broe, M.6
-
25
-
-
0021675060
-
Two new methods for separating and quantifying bone and liver alkaline phosphatase isoenzymes in plasma
-
Rosalki SB, Ying Foo A: Two new methods for separating and quantifying bone and liver alkaline phosphatase isoenzymes in plasma. Clin Chem 1986:30: 1182-1186.
-
(1986)
Clin Chem
, vol.30
, pp. 1182-1186
-
-
Rosalki, S.B.1
Ying Foo, A.2
-
26
-
-
0028959127
-
Two bone alkaline phosphatase assays compared with osteocalcin as a marker of bone formation in healthy elderly woman
-
Bounian AA, Scheffer PG, Ooms ME, Lips P, Netclenbos C: Two bone alkaline phosphatase assays compared with osteocalcin as a marker of bone formation in healthy elderly woman. Clin Chem 1995;41:196-199.
-
(1995)
Clin Chem
, vol.41
, pp. 196-199
-
-
Bounian, A.A.1
Scheffer, P.G.2
Ooms, M.E.3
Lips, P.4
Netclenbos, C.5
-
27
-
-
0027447930
-
Multicenter evaluation of Iso-ALP lest kit for measurement of bone alkaline phosphatase activity in scrum and plasma
-
Rosalki SB, Ying Foo A, Burlina A, Prellwitz W, Stieber P, Neumeier D, Klein G, Poppe WA, Bodenmüller H: Multicenter evaluation of Iso-ALP lest kit for measurement of bone alkaline phosphatase activity in scrum and plasma. Clin Chem 1993:39:648-652.
-
(1993)
Clin Chem
, vol.39
, pp. 648-652
-
-
Rosalki, S.B.1
Ying Foo, A.2
Burlina, A.3
Prellwitz, W.4
Stieber, P.5
Neumeier, D.6
Klein, G.7
Poppe, W.A.8
Bodenmüller, H.9
-
28
-
-
0027454352
-
Assessment of scrum levels of bone alkaline phosphatase with a new immunometric assay in patients with metabolic bone disease
-
Garnero P, Delmas PD: Assessment of scrum levels of bone alkaline phosphatase with a new immunometric assay in patients with metabolic bone disease. J Clin Endocrinol Metab 1993:77:1046-1053.
-
(1993)
J Clin Endocrinol Metab
, vol.77
, pp. 1046-1053
-
-
Garnero, P.1
Delmas, P.D.2
-
29
-
-
0028268907
-
Characteristics of a two-site immunoradiometric assay for human skeletal alkaline phosphatase in serum
-
Panigrahi K, Delmas PD, Singer F, Ryan W, Reiss O, Fisher R, Miller PD, Mizrahi, Darte C, Kress BC: Characteristics of a two-site immunoradiometric assay for human skeletal alkaline phosphatase in serum. Clin Chem 1994:40:822-828.
-
(1994)
Clin Chem
, vol.40
, pp. 822-828
-
-
Panigrahi, K.1
Delmas, P.D.2
Singer, F.3
Ryan, W.4
Reiss, O.5
Fisher, R.6
Miller, P.D.7
Mizrahi, D.C.8
Kress, B.C.9
-
30
-
-
0028986688
-
Biochemical markers of bone metabolism in the assessment of osteoporosis
-
Bettica P, Moro L: Biochemical markers of bone metabolism in the assessment of osteoporosis. J Ini Fed C'lin C’hcm 1995:7:16-22.
-
(1995)
J Ini Fed C'lin C’hcm
, vol.7
, pp. 16-22
-
-
Bettica, P.1
Moro, L.2
-
32
-
-
0028031664
-
Characterization of immunoreac-tive forms of human osteocalcin generated in vivo and in vitro
-
Garnero P, Grimaux M, Seguin P, Delmas PD: Characterization of immunoreac-tive forms of human osteocalcin generated in vivo and in vitro. J Bone Minenr Res 1994:9:255-264.
-
(1994)
J Bone Minenr Res
, vol.9
, pp. 255-264
-
-
Garnero, P.1
Grimaux, M.2
Seguin, P.3
Delmas, P.D.4
-
34
-
-
0026621627
-
Diurnal variation in serum markers of type I collagen synthesis and degradation in healthy premenopausal women
-
Hassager C, Risteli J, Risteli L, Jensen SB, Christiansen C: Diurnal variation in serum markers of type I collagen synthesis and degradation in healthy premenopausal women. J Bone Miner Res 1992:7:1307-1311.
-
(1992)
J Bone Miner Res
, vol.7
, pp. 1307-1311
-
-
Hassager, C.1
Risteli, J.2
Risteli, L.3
Jensen, S.B.4
Christiansen, C.5
-
35
-
-
8944258225
-
Pyridinium-Crosslinks als Kno-chenresorptionsmarkcr: Therapie-Monitoring bei maligner Osteolyse
-
Engler H, Thürlimann B, Bacchus L, Riesen W: Pyridinium-Crosslinks als Kno-chenresorptionsmarkcr: Therapie-Monitoring bei maligner Osteolyse. Schweiz Med Wochenschr 1995:125(suppl 69):57S (abstract).
-
(1995)
Schweiz Med Wochenschr
, vol.125
, pp. 57S
-
-
Engler, H.1
Thürlimann, B.2
Bacchus, L.3
Riesen, W.4
-
36
-
-
0026720343
-
Serum concentration of the cross-linked carboxyterminal tclopeptide of type I collagen (1CTP) is a useful prognostic indicator in multiple myeloma
-
Elomaa I, Virkkunen P, Risteli L, Risteli J: Serum concentration of the cross-linked carboxyterminal tclopeptide of type I collagen (1CTP) is a useful prognostic indicator in multiple myeloma. Br J Cancer 1992;66:337-341.
-
(1992)
Br J Cancer
, vol.66
, pp. 337-341
-
-
Elomaa, I.1
Virkkunen, P.2
Risteli, L.3
Risteli, J.4
-
37
-
-
0026576624
-
Serum bone alkaline phosphatase and CA 549 in breast cancer with bone métastasés
-
Cooper EH, Forbes MA, Hancock AK, Parker D, Laurence V: Serum bone alkaline phosphatase and CA 549 in breast cancer with bone métastasés. Biomed Phar-macother 1992;46:31-36.
-
(1992)
Biomed Phar-Macother
, vol.46
, pp. 31-36
-
-
Cooper, E.H.1
Forbes, M.A.2
Hancock, A.K.3
Parker, D.4
Laurence, V.5
-
38
-
-
84943462138
-
Significance of bone alkaline phosphatase. CA 15-3 and CEA in the detection of bone métastasés during the follow-up of patients suffering from breast carcinoma
-
Stieber P, Nagel D, Ritzke C, Rössler N, Kirsch CM, Eiermann W, Fateh-Mogha-dam A: Significance of bone alkaline phosphatase. CA 15-3 and CEA in the detection of bone métastasés during the follow-up of patients suffering from breast carcinoma. Eur J C'lin Chem Clin Biochem 1992:30:809-814.
-
(1992)
Eur J C'lin Chem Clin Biochem
, vol.30
, pp. 809-814
-
-
Stieber, P.1
Nagel, D.2
Ritzke, C.3
Rössler, N.4
Kirsch, C.M.5
Eiermann, W.6
Fateh-Moghadam, A.7
-
39
-
-
0028322227
-
Monitoring skeletal cancer métastasés with the bone isoenzyme of tissue unspecific alkaline phosphatase
-
Burlina A, Rubin D, Secchiero S, Scacovelli L, Zaninotto M, Plebani M: Monitoring skeletal cancer métastasés with the bone isoenzyme of tissue unspecific alkaline phosphatase. Clin Chim Acta 1994,226:151-158.
-
(1994)
Clin Chim Acta
, vol.226
, pp. 151-158
-
-
Burlina, A.1
Rubin, D.2
Secchiero, S.3
Scacovelli, L.4
Zaninotto, M.5
Plebani, M.6
-
40
-
-
8944249889
-
Knochenstoffwechsel: Biochemie und klinischchemische Diagnostik
-
Woitge HW, Scibel MJ, Ziegler R: Knochenstoffwechsel: Biochemie und klinischchemische Diagnostik. Klin Chem-Mitt 1993:24:309-331.
-
(1993)
Klin Chem-Mitt
, vol.24
, pp. 309-331
-
-
Woitge, H.W.1
Scibel, M.J.2
Ziegler, R.3
-
41
-
-
0029008799
-
Type I collagen degradation product (ICTP) gives information about the nature of bone métastasés and has prognostic value in prostate cancer
-
Kylmala T, Tammela TL, Risteli L, Risteli J, Kontturi M, Elomaa I: Type I collagen degradation product (ICTP) gives information about the nature of bone métastasés and has prognostic value in prostate cancer. Br J Cancer 1995:71:1061-1064.
-
(1995)
Br J Cancer
, vol.71
, pp. 1061-1064
-
-
Kylmala, T.1
Tammela, T.L.2
Risteli, L.3
Risteli, J.4
Kontturi, M.5
Elomaa, I.6
-
42
-
-
0027566654
-
Procollagen type I carboxy terminal propeptide as a marker of osteoblastic bone métastasés
-
Francini G, Gonnelli S, Pctrioli R, et al: Procollagen type I carboxy terminal propeptide as a marker of osteoblastic bone métastasés. Cancer Epidemiol Biomarkers Prev 1993:2:125-129.
-
(1993)
Cancer Epidemiol Biomarkers Prev
, vol.2
, pp. 125-129
-
-
Francini, G.1
Gonnelli, S.2
Pctrioli, R.3
-
43
-
-
0028154903
-
Scrum levels of carboxyterminal propeptide of type I procollagen in cancer patients with osteoblastic and osteolytic bone métastasés
-
Piovesan A, Berruti A, Osella G, et al: Scrum levels of carboxyterminal propeptide of type I procollagen in cancer patients with osteoblastic and osteolytic bone métastasés. Int J Biol Markers 1994:9:243-246.
-
(1994)
Int J Biol Markers
, vol.9
, pp. 243-246
-
-
Piovesan, A.1
Berruti, A.2
Osella, G.3
-
44
-
-
0023693335
-
Wheat-germ agglutinin method for measuring bone and liver isoenzymes of alkaline phosphatase assessed in postmenopausal osteoporosis
-
Sorensen S: Wheat-germ agglutinin method for measuring bone and liver isoenzymes of alkaline phosphatase assessed in postmenopausal osteoporosis. Clin Chem 1988;34:1636-1640.
-
(1988)
Clin Chem
, vol.34
, pp. 1636-1640
-
-
Sorensen, S.1
-
45
-
-
0022907646
-
Quantification of bone alkaline phosphatase in serum by precipitation with wheat-germ: A simplified method and its clinical plausibility
-
Behr W, Barnert J: Quantification of bone alkaline phosphatase in serum by precipitation with wheat-germ: A simplified method and its clinical plausibility. Clin Chem 1986:32:1960-1966.
-
(1986)
Clin Chem
, vol.32
, pp. 1960-1966
-
-
Behr, W.1
Barnert, J.2
|